SCHEMBL5567969

SCHEMBL5567969

C[C@H]1CN(c2cc(Cl)ccc2N)CCN1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.52
LMNA P02545 2/20 0.52
XIAP P98170 5/20 0.44
BIRC2 Q13490 5/20 0.44
NR1H4 Q96RI1 1/20 0.41
HTR3E A5X5Y0 1/20 0.41
HTR3B O95264 1/20 0.41
HTR3A P46098 1/20 0.41
HTR3D Q70Z44 1/20 0.41
HTR3C Q8WXA8 1/20 0.41
MAPK13 O15264 1/20 0.41
MAPK12 P53778 1/20 0.41
MAPK11 Q15759 1/20 0.41
MAPK14 Q16539 1/20 0.41
POLB P06746 1/20 0.41
BCL2A1 Q16548 2/20 0.41
HRH4 Q9H3N8 1/20 0.41
HTR2C P28335 1/20 0.39
KDM4E B2RXH2 1/20 0.39
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5567965 1.00 ALDH1A1 (0.52) ALDH1A1LMNAXIAPBIRC2NR1H4
SCHEMBL5569136 1.00 ALDH1A1 (0.52) ALDH1A1LMNAXIAPBIRC2NR1H4
SCHEMBL1901039 0.83 ALDH1A1 (0.63) ALDH1A1LMNAXIAPBIRC2HTR3E
SCHEMBL1904488 0.83 ALDH1A1 (0.63) ALDH1A1LMNAXIAPBIRC2HTR3E
SCHEMBL1901041 0.83 ALDH1A1 (0.63) ALDH1A1LMNAXIAPBIRC2HTR3E
SCHEMBL6873155 0.81 ALDH1A1 (0.48) ALDH1A1LMNAXIAPBIRC2HTR3E
SCHEMBL3973534 0.80 HTR3E (0.68) ALDH1A1LMNAXIAPBIRC2HTR3E
SCHEMBL6023527 0.80 BIRC2 (0.46) ALDH1A1LMNABIRC2HTR3EHTR3B
SCHEMBL1847071 0.79 ALDH1A1 (0.52) ALDH1A1LMNAXIAPBIRC2HTR3E
SCHEMBL2249569 0.79 ALDH1A1 (0.52) ALDH1A1LMNAXIAPBIRC2HTR3E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100457738-C Aryloxyphenyl and arylsulfanylphenyl piperazine derivatives LUNDBECK & CO AS H (DK) 2009-02-04 CN disclosed
EP-1458689-B1 ARYLOXYPHENYL AND ARYLSULFANYLPHENYL DERIVATIVES LUNDBECK & CO AS H (DK) 2007-04-11 EP disclosed
US-7067501-B2 Aryloxyphenyl and arylsulfanylphenyl derivatives H. LUNDBECK A/S (DK) 2006-06-27 US disclosed
US-20050171061-A1 Aryloxyphenyl and arylsulfanylphenyl derivatives H. LUNDBECK A/S (DK) 2005-08-04 US disclosed
CN-1606548-A Aryloxyphenyl and Arylthiophenyl Derivatives LUNDBECK & CO AS H (DK) 2005-04-13 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171061-A1 Aryloxyphenyl and arylsulfanylphenyl derivatives SLC1A5, SLC6A7, SLC6A19 ALDH1A1 1022/4885LMNA 4344/4885XIAP 2879/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.